Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe page revision level was updated from v3.5.4 to v3.5.5, indicating a small internal update to the page metadata.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This reflects a technical site update and does not modify the study content or displayed results.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating a minor administrative update to the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.0 was added; Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.